Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT

Ryan, CE, Sahaf, B, Logan, AC et al. (13 more authors) (2016) Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT. Blood, 128 (25). pp. 2899-2908. ISSN 0006-4971

Abstract

Metadata

Authors/Creators:
  • Ryan, CE
  • Sahaf, B
  • Logan, AC
  • OBrien, S
  • Byrd, JC
  • Hillmen, P https://orcid.org/0000-0001-5617-4403
  • Brown, JR
  • Dyer, MJS
  • Mato, AR
  • Keating, MJ
  • Jaglowski, S
  • Clow, F
  • Rezvani, AR
  • Styles, L
  • Coutre, SE
  • Miklos, DB
Dates:
  • Published: 22 December 2016
  • Accepted: 25 October 2016
  • Published (online): 1 November 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Aug 2017 09:35
Last Modified: 25 Aug 2017 09:35
Status: Published
Publisher: American Society of Hematology
Identification Number: https://doi.org/10.1182/blood-2016-06-715284
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics